Literature DB >> 28584185

TLR-3/9 Agonists Synergize with Anti-ErbB2 mAb-Letter.

Anna H Turaj1, Lekh N Dahal1, Stephen A Beers1, Mark S Cragg1, Sean H Lim2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28584185     DOI： 10.1158/0008-5472.CAN-17-0412

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  2 in total

1.  Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linking.

Authors:  Anna H Turaj; Kerry L Cox; Christine A Penfold; Ruth R French; C Ian Mockridge; Jane E Willoughby; Alison L Tutt; Jordana Griffiths; Peter W M Johnson; Martin J Glennie; Ronald Levy; Mark S Cragg; Sean H Lim
Journal:  Sci Rep       Date:  2018-02-02       Impact factor: 4.379

2.  Antibody Tumor Targeting Is Enhanced by CD27 Agonists through Myeloid Recruitment.

Authors:  Anna H Turaj; Khiyam Hussain; Kerry L Cox; Matthew J J Rose-Zerilli; James Testa; Lekh N Dahal; H T Claude Chan; Sonya James; Vikki L Field; Matthew J Carter; Hyung J Kim; Jonathan J West; Lawrence J Thomas; Li-Zhen He; Tibor Keler; Peter W M Johnson; Aymen Al-Shamkhani; Stephen M Thirdborough; Stephen A Beers; Mark S Cragg; Martin J Glennie; Sean H Lim
Journal:  Cancer Cell       Date:  2017-11-30       Impact factor: 31.743
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.